drugset / Trial / NCT02385058
Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the efficacy and safety of the combination of mebendazole plus quinfamide for the treatment of intestinal helminthiasis and amoebiasis in Mexican population.
Timeline
- Start
- 2005-10
- Primary completion
- 2006-01
- Completion
- 2006-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mebendazole | Small molecule | 600 mg | Oral |
| Subject | Quinfamide | Small molecule | 200 mg | Oral |